Clinical Trial Update: Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) [Phase 3]

View source ↗

Summary

Phase 3 trial POLAR-M investigating preventive treatment for oxaliplatin-induced peripheral neuropathy in metastatic colorectal cancer was terminated; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer

Snippet

Sponsor: Egetis Therapeutics | Conditions: Colorectal Cancer, Chemotherapy-induced Peripheral Neuropathy | Phase 3 | Status: TERMINATED | Results posted: 2021-12-17